Promising Growth Stocks To Watch Now - March 7th

Key Points

• MarketBeat’s screener highlights three Growth stocks to watch—Prologis (PLD), Teledyne Technologies (TDY), and Ascendis Pharma (ASND)—each ranked by highest recent dollar trading volume among Growth stocks.
• Prologis is the global leader in logistics real estate, owning or investing in roughly 1.2 billion square feet across 19 countries, positioning it to benefit from sustained e‑commerce and supply‑chain demand.
• Teledyne provides advanced sensors, digital imaging and semiconductor components for industrial growth markets, while Ascendis Pharma sells SKYTROFA for growth‑hormone deficiency and is advancing multiple endocrinology and oncology candidates.

Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase revenues and earnings faster than the overall market, usually because they operate in expanding markets or have strong competitive advantages. They typically reinvest profits into growth rather than paying dividends, leading to higher valuation multiples and greater price volatility as investors focus on future capital appreciation. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.